4th Annual Recombinant Antibodies Conference January 18, 2011

The 4th Annual Recombinant Antibodies Conference seeks to highlight the importance of monoclonal antibodies in the world of proteins. The Conference will showcase how industry leaders are answering challenges such as decreasing immunogenicity, improving cell line productivity and decreasing manufacturing costs.

Matthew Sleeman, Director of Biology, will speak on the topic of "Modulating pharmacokinetics to improve in vivo efficacy."

Lolke De Haan, Head of Toxicology, will speak on the topic of "Alternative strategies for toxicity testing of species-specific biopharmaceuticals" and "Immunogenicity assessment of monoclonal antibodies intended for in vivo clinical use."

MedImmune is a sponsor.